Author: ANHUSA

New Bill to Update Vaccine Court

A new bill would reform the Vaccine Injury Compensation Program (VICP), but falls far short of fixing this broken program. The bill includes many important reforms, like increasing the cap on compensations and extending the statute of limitations on injuries from three to five years, among other things we will detail below. But there is… Continue reading New Bill to Update Vaccine Court

FDA Moves Toward Monopoly Medicine

A regulation that threatens supplement access is gaining traction. Action Alert! A well-organized, coordinated campaign from the FDA and Big Pharma is threatening access to the supplements you depend on. Using the false premise that supplements are unsafe, the FDA is working to gain more power over the regulation of supplements in order to further… Continue reading FDA Moves Toward Monopoly Medicine

The Future of COVID Vaccines

Will we get the data necessary to be able to make informed choices about COVID vaccination? Action Alert! A number of weeks ago, our friends at ANH International released a white paper detailing how autoimmune patients are at an increased risk of serious adverse events from COVID vaccination. As such, autoimmune patients have a legitimate… Continue reading The Future of COVID Vaccines

Do You Know What’s in Your Makeup?

New research shows that many cosmetics contain dangerous chemicals with known human health risks. Action Alert! Cosmetics is a $20 billion industry, but companies aren’t transparent about the fact that a high percentage of these products are made with PFAS, or “forever” chemicals that cause a host of human health and environmental problems. But you… Continue reading Do You Know What’s in Your Makeup?

Double Whammy for Autoimmune Patients?

We’ve been detailing the scientific evidence showing the increased risk of serious adverse events for autoimmune patients receiving the COVID vaccine. Emerging data is now showing that patients with compromised immune systems, such as those on immunosuppressive medications and organ transplant recipients, do not generate as strong an immune response to the COVID vaccines as… Continue reading Double Whammy for Autoimmune Patients?

FDA Approves Expensive, Ineffective Alzheimer’s Drug

…against the advice of its own expert panel, ensuring another windfall for Big Pharma at the expense of patients and taxpayers. The FDA has approved the first new Alzheimer’s drug in years—a drug which will reportedly cost more than $56,000 per year. The FDA’s treatment of this drug—which is incredibly expensive and comes with real… Continue reading FDA Approves Expensive, Ineffective Alzheimer’s Drug